Abstract Endogenous nitric oxide (NO) is a molecule synthesized by endothelium nitric oxide synthase encoded by the ecNOS gene that plays an important role in regulating the systemic, cardiac and pulmonary circulation. Impairment in NO synthesis has been associated to many cardiovascular disorders, including coronary artery disease and hypertension. We investigated the frequency of the intron 4 VNTR ecNOS gene polymorphism in an Ivorian and an Italian population. The frequencies of the ecNOSb/b, ecNOSa/b and ecNOSa/a genotypes were 0.422, 0.476, and 0.102, respectively, for the Ivorian sample, and 0.712, 0.269, and 0.019, respectively, for the Italian population. The frequencies of ecNOS4b and ecNOS4a alleles were 0.660 and 0.340, respectively, for the Ivorian group, and 0.847 and 0.153, respectively, for the studied Italian population. Genotype frequencies were in Hardy-Weinberg equilibrium in both populations. The Ivorian population showed a significantly higher frequency of the ecNOS4a allele compared to other African and non-African populations, while the Italian sample confirmed the high genetic homogeneity of this polymorphism among Europeans. The maldistribution of endothelial ecNOS polymorphisms between populations could be the results of differential exposure to selection pressures in Africa and during the out-of-Africa expansion.
Introduction
Endogenous nitric oxide (NO) is a highly reactive molecule that plays an important role in the regulation of vascular smooth muscle cell proliferation and migration, in the endothelial permeability, and in the endothelial-leucocyte interaction [1] [2] [3] . Because of these properties, NO has been recognized as a regulator of the systemic, cardiac and pulmonary circulation [1] , with an important antithrombotic and antimicrobial role [2, 3] . An impairment of NO production has been related to many disorders, including coronary artery disease (CAD) [4] , ischemic stroke [5] , hypertension [6] , renal disease [7] , and Alzheimer's syndrome [8] . High level of NO was associated to DNA damage, cell cycle arrest, and cellular apoptosis [9] , whereas reduction in basal NO release may predispose to hypertension, thrombosis, vasospasm and atherosclerosis [10] .
NO is synthesized from the amino acid L-arginine by the nitric oxide synthase (NOS) [11] . Three distinct isoforms of NOS, neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial constitutive NOS (ecNOS) were identified in humans. ecNOS produces most of the circulating NO [12] and, together with nNOS, it is expressed in both airway and vascular endothelia. The continuously generated NO serves to maintain basal vascular NO concentrations required for normal endothelial functions and blood flow regulation.
The ecNOS is encoded by a gene located on chromosome 7q35-q36 (13) (14) (15) and organised in 26 exons spanning more than 21 kb of the genome [13] . Several polymorphisms were reported in the promoter region, exons, and introns of this gene. A significant one is represented by a 27 bp VNTR (variable number of tandem repeats) in the intron 4 [14] . The common wild-type ecNOS4b allele contains five tandem repeats, while the rare ecNOS4a allele is made of only four 27 bp repeats. Tsukada et al. [15] reported that ecNOS gene polymorphisms correlate with the circulating NO concentrations, where homozygotes ecNOS4b/b and ecNOS4a/a exhibit the highest and the lowest NO levels, respectively. Moreover, ecNOS4a allele was associated with the pathogenesis of coronary heart disease [4, 16] , lung disease [17] , hypertension [6, 18] , atopic asthma [19] , and early-onset colorectal cancer [20] .
Most investigations on this gene polymorphism are case-control studies, while only few papers assessed the frequency distribution of this polymorphism in populations worldwide. The aim of this study was to investigate the genetic variability at the ecNOS locus in an African population from Ivory Coast and in a European population from Italy, for which no data was available. We also compared our results with those reported from other populations, in particular from Africa and Europe.
Materials and methods

Population studied
The African sampling was performed in Ouangolodougou, a rural village of 20.000 inhabitants located on the Northern Ivory Coast. One hundred and twenty-eight unrelated individuals (59 males and 69 females, mean age 31.9 ± 14.5) were analyzed. The Italian sampling was performed in Piedmont, a region of Northern Italy. Three hundred and sixty-five individuals (168 males and 197 females, mean age ± S.E. 59.98 ± 1.42) were analyzed. All the subjects were healthy volunteers and had received information about the study. The study was approved by the local ethics committee and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
PCR Analysis
Peripheral blood samples (5-10 ml venipuncture) were collected in heparinized vacutainers and stored at -20°C.
To extract DNA we used ChelexÒ solution protocol [21] . To determine the genotype, a genomic fragment of intron 4 from the ecNOS gene was amplified by PCR, using the following primers: forward primer 5 0 -AGGCCCTATGGT AGTGCCTTG-3 0 and the reverse primer 5 0 -TCTCTTAGT GCTGTGGTCAC-3 0 . PCR reactions were carried out in a total volume of 25 ll containing 10 ng of DNA (template), with a final concentration of 19 Reaction Buffer, 1.5 mM of MgCl 2 , 5% of DMSO, 250 lM of dNTPs, 0.5 lM of each primer, and 1U/sample of Taq DNA polymerase (Fischer, U.S.). The reaction profile was: 30 cycles of 94°C for 1 min, 56°C for 1 min, 72°C for 1 min, with a final extension at 72°C for 10 min. PCR products were separated by electrophoresis on a 4% Nusive high resolution agarose gel and visualized by ethidium bromide staining. Amplification yielded either a 420 bp (five repeats of the 27-bp sequence) fragment or a 393 bp (four repeats of the 27-bp sequence) fragment or both (heterozygous genotype). 10% of the samples were amplified twice to assess the result's accuracy. Moreover, in order to confirm that the amplified products represent genuine ecNOS intron 4 regions, selected PCR products corresponding to 10 ecNOS4a/a and 20 ecNOS4b/b genotypes, were validated by sequencing both strands.
Statistical analysis
The allele and genotype frequencies were determined using GENEPOP v1.2. Hardy-Weinberg equilibrium was evaluated by the v 2 test using a 95% confidence interval. Allele frequencies were compared with those reported for other European and African populations, through contingency tables analyzed with a v 2 test. Because of reported gender differences in NO production [22, 23] , allele and genotype frequencies of the ecNOS polymorphisms were also analyzed separately in men and women.
Results and discussion
Frequency distribution of ecNOS 27-bp repeat polymorphism of intron 4 in the study groups is shown in Table 1 . No statistical differences between sexes were found in both the genotype and allele frequencies ( Table 1) . The ecNOS intron 4 VNTR polymorphism was previously investigated in several human populations (Table 2) , mostly to assess its association with various type of diseases. Data showed a significant (P \ 0.001) decreasing frequency of the ecNOS4a allele from Africa to Europe, America and Asia, probably related to a founder effect consequent to ancient migrations of geographically distinct groups from Africa towards the other continents. The Ivorians here analysed showed allele frequencies similar to previously characterised Ivorian and AfricanAmerican samples, but significantly different (P \ 0.001) from some North African (Tunisia, Algeria and Morocco) and African-Brazilian populations ( Table 2 ). The genetic structure among Africans evidenced by ecNOS polymorphisms is congruent with data from numerous genetic systems (e.g. mitochondrial DNA and Y chromosome SNPs) and could be attributed to the different evolutionary histories of the saharan and sub-saharan ethnic groups [24] .
Viceversa, the Italian population did not show significant differences with respect to other European populations (with the exception of the Dutch and Turkish), confirming the high genetic homogeneity of Italy and Europe in the distribution of this polymorphism.
Our West African sample showed a high level of heterozygosity, similarly to a previously analysed Ivorian population and coherently with most genetic surveys demonstrating that the Africans have consistently greater genetic diversity than other populations [25, 26] .
In general, ecNOS gene function has been suggested to play a role in various cardiovascular diseases. In particular, the ecNOS4a/b polymorphism has been significantly associated with NO plasma concentrations and CAD [15, [27] [28] [29] [30] . Homozygotes ecNOS4a/a were shown a 20% reduction of NO metabolites levels in comparison to subjects with the ecNOS4b/b genotype [15] . Moreover, the ecNOS4a allele resulted to be an independent risk factor for myocardial infarction [31] . A maldistribution of endothelial ecNOS genetic variants has been invoked to explain differences in NO-mediated effects and response to drugs among African and non-African Individuals [32] . Young et al. (2005) [33] have suggested that susceptibility to hypertension and cardiovascular diseases may be ancestral and that differential susceptibility to hypertension could be due to differential exposure to selection pressures in Africa and during the out-of-Africa expansion. It is plausible that the high frequency of the ecNOS4a allele and the high heterozygosity among West African populations is the ancestral variability condition for the ecNOS polymorphism as result of local adaptation to hot environments.
In conclusion, we reported new frequency data on ec-NOS intron 4 VNTR polymorphism in an African and a Caucasian population, extending previous observations obtained from other worldwide populations. Considering the implication of this polymorphism in many diseases and the scarcity of data about the prevalence of these diseases especially among African populations, further studies are needed to address the impact of selective constraints on the variability associated to this polymorphism in different populations and ethnic groups.
